Anti-His tag Antibody

Anti-His tag Antibody (Mouse Monoclonal 抗体) の製品情報

製品名
Anti-His tag Antibody
検証済のアプリケーション
WB
特異性
His tag
免疫原
A synthetic peptide corresponding to 6×His
調製
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with a synthetic peptide. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
ソース
Monoclonal
精製
Protein A
緩衝液
0.2 μm filtered solution in PBS
標識物
Unconjugated
状態
Liquid
配送方法
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
保存条件
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Anti-His tag Antibody (Mouse Monoclonal 抗体) 検証済のアプリケーション

アプリケーション 推奨希釈率/用量
WB 1/1000-1/10000
Please Note: Optimal concentrations/dilutions should be determined by the end user.

Anti-His tag Antibody (Mouse Monoclonal 抗体) の画像

Detection Limit

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: His-Human PA2G4(10ng)

Lane B: His-Human PA2G4(5ng)

Lane C: His-Human PA2G4(2ng)

Lane D: His-Human PA2G4(1ng)

Lane E: His-Human PA2G4(0.5ng)

Lane F: His-Human PA2G4(0.2ng)

Lane G: Human B7-2-His(10ng)

Lane H: Human B7-2-His(5ng)

Lane I: Human B7-2-His(2ng)

Lane J: Human B7-2-His(1ng)

Lane K: Human B7-2-His(0.5ng)

Lane L: Human B7-2-His(0.2ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize the protein with 10×His tag.

Anti-10×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: Human IL2Ra-His(50ng)

Lane B: Human IL6R-His(50ng)

Lane C: Human AZGP1-His(100ng)

Lane D: Human ART3-His(20ng)

Lane E: Human LILRA3-His(20ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize the protein with 6×His tag.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: His-Mouse TNFSF9(50ng)

Lane B: His-Human AKR1C2(200ng)

Lane C: His-Human LYPLA2(50ng)

Lane D: Human MOG-His(100ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: Human IL2Ra-His(50ng)

Lane B: Human IL6R-His(50ng)

Lane C: Human AZGP1-His(100ng)

Lane D: Human ART3-His(20ng)

Lane E: Human LILRA3-His(20ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Negative binding protein without His tag.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: Human C100RF54-Fc(100ng)

Lane B: Rat B7H5-Fc(100ng)

Lane C: Rhesus C9H10orf54-Fc(100ng)

Lane D: S3-Mouse ALK6-Fc(100ng)

Lane E: Human LAG3-Fc(100ng)

Lane F: GST-Human MKI67(100ng)

Lane G: GST-Human CD247(100ng)

Lane H: MYC-GST(100ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize protein with His tag (internal).

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: TrxA-His-EK-Human APOE(100ng)

Lane B: TrXA-His-EK-Human BCL6(100ng)

Lane C: Trx-His-EK-Human SOCS3(100ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize His tag at C-terminal of the protein.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: Human LRG1-His(50ng)

Lane B: Human 4-1BB-His(50ng)

Lane C: Human SLAMF1-His(50ng)

Lane D: Human ALPL-His(100ng)

Lane E: Human IL2Ra-His(50ng)

Lane F: Human IL6R-His(50ng)

Lane G: Human AZGP1-His(100ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize His tag at N-terminal of the protein.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Sample:Recombiant Protein

Lane A: His-Human TPO(100ng)

Lane B: His-Mouse CLEC7A(200ng)

Lane C: His-Human LYPLA2(50ng)

Lane D: His-Human COCH(200ng)

Lane E: His-Mouse TFRC(100ng)

Lane F: His-Human HSPA1A(100ng)

Lane G: His-Human PA2G4(50ng)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize His tag fusion proteins which expressed by Baculovirus.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Lane A: Negative control

Lane B: His-Human LYPLA2 transfected Baculovirus Lysate(2ug)

Lane C: Human AZGP1-His transfected Baculovirus Lysate(2ug)

Lane D: Human IL2Ra-His transfected Baculovirus Lysate(2ug)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize His tag fusion proteins which expressed by E. coli.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Lane A: Negative control

Lane B: Human M2E1-His transfected E.coli Lysate(0.5ug)

Lane C: His-sSPA transfected E.coli Lysate(0.5ug)

Lane D: His-Human GH1 transfected E.coli Lysate(0.5ug)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

Recognize His tag fusion proteins which expressed by 293 cell.

Anti-6×His Tag mouse monoclonal antibody at 1:1000 dilution.

Lane A: Negative control

Lane B: His-Human LYPLA2 transfected 293 Cell Lysate(2ug)

Lane C: His-Human AKR1C2 transfected 293 Cell Lysate(2ug)

Lane D: Human LILRA3-His transfected 293 Cell Lysate(2ug)

Secondary

Rabbit Anti-Mouse IgGF(ab)2/HRP at 1:10000 dilution.

Developed using the ECL technique.

Performed under reducing conditions.

カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください